RPRX Live signals | Maximize Profits with Getagraph.com

SELL 3536 min ago

@ $27.07

Issued: 31 May 2024 @ 15:12

Return: 1.26%

Previous signal: May 31 - 13:40

Previous signal: Buy

Return: 0.37 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States...

Stats
Today's Volume	6.68M
Average Volume	2.69M
Market Cap	12.36B
EPS	$0 ( 2024-05-14 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0.200 ( 2023-11-16 )
Next Dividend	$0 ( N/A )
P/E	15.40
ATR14	$0.784 (2.86%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-13	Hite Christopher	Buy	300 000	Class A Ordinary Shares
2024-05-13	Hite Christopher	Sell	30 000	LP interests in RPI US Partners 2019, LP
2024-03-28	Fernandez Henry A	Buy	1 240	Class A Ordinary Shares
2024-03-28	Bassler Bonnie L	Buy	1 240	Class A Ordinary Shares
2024-02-20	Riggs Rory B	Buy	300 000	Class A Ordinary Shares

INSIDER POWER
-27.59
Last 100 transactions
Buy: 3 608 362 \| Sell: 6 961 055

Volume Correlation

Long: 0.92 (very strong)

Short: -0.77 (moderate negative)

Signal:(66) Neutral

Royalty Pharma plc Correlation

10 Most Positive Correlations
GANX	0.85
REE	0.801

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Royalty Pharma plc Correlation - Currency/Commodity

0.80
( strong )

0.70
( moderate )

0.00
( neutral )

0.88
( strong )

-0.21
( neutral )

Royalty Pharma plc Financials

Annual	2023
Revenue:	$2.35B
Gross Profit:	$1.79B (76.19 %)
EPS:	$2.54

FY	2023
Revenue:	$2.35B
Gross Profit:	$1.79B (76.19 %)
EPS:	$2.54

FY	2022
Revenue:	$2.24B
Gross Profit:	$2.23B (99.75 %)
EPS:	$0.0978

FY	2021
Revenue:	$2.29B
Gross Profit:	$0.00 (0.00 %)
EPS:	$0.922

Financial Reports:

No articles found.

Royalty Pharma plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.190 (N/A)	$0.190 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Royalty Pharma plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.67 - Increase likely (53.44%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2020-09-14
Last Dividend	$0.200	2023-11-16
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	$2.54	--
Avg. Dividend % Per Year	1.17%	--
Score	4.93	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.67
Div. Directional Score	9.42	--

Next Divdend (Est)
(2024-07-01)

$0.205 Estimate 38.46 %

Dividend Stability

0.77 Good

Dividend Score

4.93

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$0.300	0.67%
2021	$0.680	1.45%
2022	$0.760	1.93%
2023	$0.800	2.03%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.357	1.500	2.86	4.29	[0 - 0.5]
returnOnAssetsTTM	0.0495	1.200	8.35	10.00	[0 - 0.3]
returnOnEquityTTM	0.126	1.500	9.72	10.00	[0.1 - 1]
payoutRatioTTM	0.455	-1.000	5.45	-5.45	[0 - 1]
currentRatioTTM	12.52	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	12.48	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	6.77	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.381	-1.500	3.66	-5.49	[0 - 0.6]
interestCoverageTTM	5.10	1.000	9.22	9.22	[3 - 30]
operatingCashFlowPerShareTTM	5.86	2.00	8.05	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.29	2.00	8.85	10.00	[0 - 20]
debtEquityRatioTTM	0.945	-1.500	6.22	-9.33	[0 - 2.5]
grossProfitMarginTTM	0.474	1.000	5.44	5.44	[0.2 - 0.8]
operatingProfitMarginTTM	0.420	1.000	3.61	3.61	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.428	1.000	8.73	8.73	[0.2 - 2]
assetTurnoverTTM	0.139	0.800	-2.41	-1.927	[0.5 - 2]
Total Score				11.16

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.39	1.000	8.55	0	[1 - 100]
returnOnEquityTTM	0.126	2.50	9.82	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.29	2.00	9.24	10.00	[0 - 30]
dividendYielPercentageTTM	2.99	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.86	2.00	8.05	10.00	[0 - 30]
payoutRatioTTM	0.455	1.500	5.45	-5.45	[0 - 1]
pegRatioTTM	2.21	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	1.174	1.000	10.00	0	[0.1 - 0.5]
Total Score				7.67

Royalty Pharma plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.